Form 8-K - Current report:
SEC Accession No. 0001437749-20-016227
Filing Date
2020-08-03
Accepted
2020-08-03 08:33:18
Documents
34
Period of Report
2020-08-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20200731_8k.htm 8-K 22840
2 EXHIBIT 99.1 ex_196385.htm EX-99.1 19241
3 a01.jpg GRAPHIC 29898
4 a02.jpg GRAPHIC 107142
5 a03.jpg GRAPHIC 37439
6 a04.jpg GRAPHIC 56715
7 a05.jpg GRAPHIC 42929
8 a06.jpg GRAPHIC 39093
9 a07.jpg GRAPHIC 51871
10 a08.jpg GRAPHIC 45632
11 a09.jpg GRAPHIC 55230
12 a10.jpg GRAPHIC 28917
13 a11.jpg GRAPHIC 58187
14 a12.jpg GRAPHIC 45992
15 a13.jpg GRAPHIC 38612
16 a14.jpg GRAPHIC 53528
17 a15.jpg GRAPHIC 42954
18 a16.jpg GRAPHIC 48162
19 a17.jpg GRAPHIC 37887
20 a18.jpg GRAPHIC 44654
21 a19.jpg GRAPHIC 55843
22 a20.jpg GRAPHIC 54501
23 a21.jpg GRAPHIC 48754
24 a22.jpg GRAPHIC 71170
25 a23.jpg GRAPHIC 29373
26 a24.jpg GRAPHIC 51631
27 a25.jpg GRAPHIC 67100
28 a26.jpg GRAPHIC 55584
29 a27.jpg GRAPHIC 48429
30 a28.jpg GRAPHIC 48688
31 a29.jpg GRAPHIC 54453
32 a30.jpg GRAPHIC 56791
33 a31.jpg GRAPHIC 34256
34 a32.jpg GRAPHIC 24611
  Complete submission text file 0001437749-20-016227.txt   2198117
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 201067972
SIC: 2834 Pharmaceutical Preparations